EIDB is headquartered on the main campus of the Walter Reed Army Institute of Research in Silver Spring, Maryland. The Institute’s legacy of infectious disease research, unparalleled expertise in vaccine and countermeasure development and world-class facilities make it a one-stop-shop for innovative solutions to health threats plaguing U.S. Service Members and allied forces.
WRAIR’s Pilot Bioproduction Facility (PBF) can produce up to 20,000 doses in its new facility for pilot studies of vaccines and drugs utilized in pre-clinical and human clinical studies and trials. It is one of only a few facilities that meets FDA and all regulatory standards, including Good Manufacturing Practices. The PBF has manufactured vaccines for dengue, malaria, HIV, Zika, enteric diseases, hepatitis A, plague, and Japanese encephalitis. Pharmaceutical companies, academia and other government agencies routinely select the PBF to produce pilot lots of promising vaccines.
Another invaluable resource, WRAIR’s Clinical Trials Center (CTC), tests new candidate drugs and vaccines to prevent and treat infectious diseases. It is structured for maximum agility, enabling a fast pivot to target and clinically evaluate products that are a top priority to DoD and national security.
The CTC is fully integrated within a network designed to bring products to market with an average of 5-10 new studies each year. Since its inception, the CTC has conducted over 150 clinical trials of drugs and vaccines for a variety of infectious diseases, including Ebola, Japanese encephalitis, Zika, HIV and many others.